Aspira Women’s Health Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementAspira Women's Health Inc. • February 10th, 2023 • In vitro & in vivo diagnostic substances • New York
Aspira Women’s Health Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
